A Yes or a No? Decicive Factors Behind Recommendations Made by the Danish Health Technology Council

Author(s)

Liljenberg D
The Danish Health Technology Council, Aalborg, 81, Denmark

Problem Statement: In 2023 the Danish Health Technology Council (DHTC) published health technology assessments (HTA) on, among others, sensor-based glucose monitors for adults with type 1 diabetes and the use of artificial intelligence (AI) in colonoscopy. The HTAs led to a recommendation for and recommendation against a national implementation of the technologies, respectively. This abstract summarizes factors that were decisive for the outcomes of the recommendations.

Description: DHTC methods dictate that four perspectives are to be examined in HTAs of health technologies: clinical effectiveness and safety, the patients’ perspective, organizational implications, and health economics. Covering these four perspectives, the Council is to decide if a health technology should be recommended for national implementation. By comparing two HTAs, with a recommendation for and against national implementation, respectively, decisive factors for the recommendation outcomes are identified.

Lessons Learned: DHTC emphasized the following elements as decisive for their recommendations:

The use of glucose monitors:

  • Leads to pronounced positive effects on several clinical outcomes
  • Has compelling, positive consequences for patients, with potential to improve patients’ treatment satisfaction, quality of life, and insight into treatment and disease
  • Is supported by a solid evidence base
  • Is appraised by clinicians as a valuable tool for improving quality of treatment and communication with patients

    In contrast, the use of AI:

    • Might constitute a risk to patient safety, if leading to the collection of unnecessary tissue samples with the risks this entails
    • Has not been evaluated with respect to patient-relevant outcomes
    • Is supported by an inadequate evidence base
    • Does not usefully support clinicians’ decision-making, who often opt out of using the AI-function

    Stakeholder perspective: DHTC bases its recommendation on a consideration of multiple factors, where patient-centeredness, perceived value amongst clinicians, and the solidity of the evidence base supporting the use of the technology were emphasized as pivotal for the outcome of the national recommendations.

    Conference/Value in Health Info

    2023-11, ISPOR Europe 2023, Copenhagen, Denmark

    Value in Health, Volume 26, Issue 11, S2 (December 2023)

    Acceptance Code

    CS17

    Topic

    Health Policy & Regulatory, Health Technology Assessment

    Topic Subcategory

    Decision & Deliberative Processes, Public Spending & National Health Expenditures, Reimbursement & Access Policy

    Disease

    Medical Devices, no-additional-disease-conditions-specialized-treatment-areas

    Explore Related HEOR by Topic


    Your browser is out-of-date

    ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

    ×